Healthbeat: Freeman Chari and Panos London report
February 14, 2009
Recently, claims have been made about a trial of a new microbicide (PRO 2000) that seems to offer some protection from HIV. Freeman Chari, a biomedical scientist with an interest in HIV, discusses the always controversial ethical considerations when conducting HIV research. Most reputable research facilities and bodies such as the World Health Organisation have in place codes of ethics governing research protocols, but do these go far enough in protecting the rights of ‘vulnerable’ people? Staying on the subject of research, a report courtesy of Panos London focuses on the sensitive subject of male circumcision in Zambia.
YOU ARE NOW LISTENING TO A HAZ PODCAST:
Related posts:








